Navigation Links
Randomized Phase III Trial Showed Erbitux Significantly Improved,Secondary Endpoints of Progression-Free Survival and Disease,Control in Metastatic Colorectal Cancer Patients

reactions and cardiopulmonary arrest, visit http://www.ERBITUX.com.

Important Safety Information

Grade 3/4 infusion reactions, rarely with fatal outcome (<1 in 1000), occurred in approximately 3% (46/1485) of patients receiving ERBITUX (Cetuximab) therapy. These reactions are characterized by rapid onset of airway obstruction (bronchospasm, stridor, hoarseness), urticaria, hypotension, and/or cardiac arrest. Severe infusion reactions require immediate and permanent discontinuation of ERBITUX therapy.

Most reactions (90%) were associated with the first infusion of ERBITUX despite the use of prophylactic antihistamines. Caution must be exercised with every ERBITUX infusion as there were patients who experienced their first severe infusion reaction during later infusions. A 1-hour observation period is recommended following the ERBITUX infusion. Longer observation periods may be required in patients who experience infusion reactions.

Cardiopulmonary arrest and/or sudden death occurred in 2% (4/208) of patients with squamous cell carcinoma of the head and neck treated with radiation therapy and ERBITUX as compared to none of 212 patients treated with radiation therapy alone. Fatal events occurred within 1 to 43 days after the last ERBITUX treatment. ERBITUX in combination with radiation therapy should be used with caution in patients with known coronary artery disease, congestive heart failure and arrhythmias. Close monitoring of serum electrolytes, including serum magnesium, potassium, and calcium during and after ERBITUX therapy is recommended.

Severe cases of interstitial lung disease (ILD), which was fatal in one case, occurred in less than 0.5% of 774 patients with advanced colorectal cancer (mCRC) receiving ERBITUX. There was one case of ILD reported in 796 patients with head and neck cancer receiving ERBITUX in clinical studies.

In clinical studies of ERBITUX, dermato
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

Post Your Comments:
(Date:11/6/2009)... Watson Pharmaceuticals, ...ical company, announced today that Paul Bisaro, Wa... provide an overview and update of the Company,s b...e Conference on Wednesday, November 11, 2009 at 12...ion will be webcast live and can be accessed on Wa...
(Date:11/6/2009)...RNewswire-FirstCall/ -- Roper Industries, Inc. (...definitive agreement to acquire Verathon, Inc., a ...The Verathon Board of Directors has approved the t... regulatory approvals and closing conditions, incl...e closing to be completed in early December. ,...
(Date:11/6/2009)...swire-USNewswire/ -- America,s Specialty Medicines...d-market and smaller innovator pharmaceutical comp...he "Affordable Health Care for America Act," intro...ller companies fear that the cumulative effect of ...r efforts to bring new medicines to market. ,...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Covering Kids 26 Families with Health Insurance is Goal of Back to School Outreach Campaign 54850 1Covering Kids 26 Families with Health Insurance is Goal of Back to School Outreach Campaign 54850 2Foreclosures Plunge People Into Depression 54848 1Foreclosures Plunge People Into Depression 54848 2CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 1CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 2CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 3
(Date:11/8/2009)..., WASHINGTON, Nov. 7 ...upak, Pitts, Kaptur, Dahlkemper, Smith, Ellsworth ...are for America Act" (H.R. 3962). The amendment ma...unding for abortion and for benefits packages that...both those who receive affordability credits and t...
(Date:11/8/2009)..., Nation,s largest network of Hispanic health ... care reform in 2009 ,, WASHINGTON, Nov. 7 /PR... Representatives showed they have heard the voice ...alth Care for America Act. Now the Senate must del...health care reform," said Dr. Jane L. Delgado, Pre...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ...ica (PhRMA) Senior Vice President Ken Johnson rele...ealth care reform bill: ,, "We are disappointed...ss echoed by millions of hardworking Americans as ...se of Representatives who voted against the bill. ...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 ..., Director, Operation Rescue Insurrecta Nex. ,...ntry have been fighting to keep child-killing by a..., Mr. Terry states: "This is a great first step ...but we have a lot of fighting ahead of us. Our rej...
(Date:11/8/2009)..., Health Care Vote Shows Who Sides With Workin...RG, Pa., Nov. 8 On the ...of Representatives for a good, balanced health car...ts scoring of how our state,s U.S. representatives...America Act. ,, The legislation, which passed ...
Breaking Medicine News(10 mins):Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2
...itish schools are concerned that children in prima...patched experts to schools to tackle inappropriate...ven have been interacting with each other in a rat...rmingham say that the local council's inappropriat...
...evices that contain higher doses of copper are mor... lower copper doses, according to a new systematic...g the copper content does not cause an increase in... effectiveness and similar side effect profile wit...
... with industry, University at Buffalo researchers ...lity tests of "allergy-friendly" hotel rooms.// ...able to other environments where indoor air qualit...in Amherst as their laboratory, the Industry-Unive...
... the University of Hong Kong say that the elderly ...ograms because of their age. It is generally felt/... chances of recovery. But the current study ...vors who received rehabilitation in Hong Kong from...
...e use of anesthetics have been recommended by most...n Academy of Pediatrics, for pain relief during in...doctors who are taught circumcision techniques are...s that 97 percent of these doctors now learn effec...
...mb today launched a new vision correction technolo...gery sight distortions. // "There are 60 cli... to treat eye ailments. The technology can be upgr...iness Rajat Goel told reporters here. The com...
Other Medicine News:Health News:Higher-Dose Copper IUDs Provide Better Pregnancy Protection 2Health News:Higher-Dose Copper IUDs Provide Better Pregnancy Protection 3Health News:Scientists Put "Allergy-Friendly" Hotel Rooms to the Test 2Health News:Scientists Put "Allergy-Friendly" Hotel Rooms to the Test 3Health News:Pain Relief During Circumcision 2
Novalis
Platinum Plus
Clinac 23EX
Clinac 2300 C/D Family
Medicine Products: